AI and APIs upend healthcare billing: CMS rule forces industry reckoning on denials, automation, and payment speed

Healthcare's modernization has long been hampered by deeply entrenched legacy infrastructure and a uniquely complex regulatory environment, making it one of the slowest sectors to adopt new technologies. As noted in early 2026, the industry only recently phased out pagers, underscoring its lag behind other sectors. Regulatory frameworks like HIPAA, while crucial for safeguarding patient data, introduce significant implementation challenges—such as conflicting data retention requirements with consumer tech standards—that complicate product development and hinder seamless user experiences. This regulatory burden means that healthcare innovations often require bespoke approaches that would be unnecessary in other industries, slowing the pace of progress considerably.

A pivotal regulatory shift began with the CMS-0057-F Interoperability and Prior Authorization Final Rule issued in January 2024, mandating that a broad array of health plans implement four distinct HL7 FHIR-based APIs—including Patient Access, Provider Access, Payer-to-Payer, and Prior Authorization—by January 1, 2027. This comprehensive framework not only modernizes prior authorization workflows but also introduces unprecedented transparency through public reporting of approval rates, denial rates, and decision timeframes, creating the first standardized, comparable dataset on prior authorization behavior in American health insurance history. Complementing CMS’s efforts, the ONC’s HTI-1 final rule requires certified EHRs to support FHIR-based data exchange, ensuring that these payer APIs can be effectively utilized by clinicians and closing a critical interoperability gap.

Perhaps most transformative is CMS’s 2024 enforcement discretion allowing payers and providers to replace the legacy X12 278 standard with an all-FHIR prior authorization workflow, effectively waiving a longstanding HIPAA mandate. This regulatory pivot enables pure-FHIR infrastructure companies to bypass traditional clearinghouses, signaling a tectonic shift in healthcare IT architecture. Coupled with parallel state regulations establishing AI guardrails and service-level agreements, these federal moves are not barriers but market-creating forcing functions that have catalyzed the emergence of programmable medical necessity as a new health technology infrastructure category, poised for pressure-testing by 2027.

The economic imperative for modernization is starkly clear given the entrenched inefficiencies: as of early 2026, 65 percent of prior authorization processes remain non-electronic, with half still conducted via fax or phone, costing the system an estimated $15 billion annually and consuming 13 physician hours per week. These dysfunctions contribute to adverse events affecting nearly one in three physicians’ patient panels, underscoring the urgent need for programmable transactions that can streamline workflows and reduce clinical burden. This confluence of regulatory momentum and economic necessity sets the stage for a fundamental overhaul of healthcare revenue and authorization systems.

The emergence of AI-driven automation in healthcare revenue cycle and prior authorization is fundamentally reshaping administrative workflows by reducing clinician burden and accelerating patient access to care. Platforms like Arbiter exemplify this shift by consolidating fragmented healthcare data into a real-time source of truth that streamlines referrals and prior authorizations, addressing critical inefficiencies exacerbated by the primary care crisis. As Dr. Robert Wachter highlights, AI is transitioning from skepticism to an essential tool poised to lower care costs and speed up prior authorization within entrenched fee-for-service models.

The federal regulatory landscape is catalyzing this AI-driven transformation by mandating the adoption of four distinct FHIR-based APIs—Patient Access, Provider Access, Payer-to-Payer, and Prior Authorization—by January 1, 2027. These APIs enable real-time prior authorization decisioning, seamless data exchange, and unprecedented transparency through public reporting of approval and denial metrics, effectively turning prior authorization into a programmable transaction. CMS’s waiver of the legacy X12 278 standard for prior authorization workflows further unlocks the potential for pure-FHIR infrastructure companies to innovate without traditional clearinghouse constraints, while ONC’s HTI-1 rule ensures certified EHRs can fully leverage these APIs, bridging payer data with clinical workflows.

By mid-2026, a wave of AI-powered solutions from companies like Amperos Health, Healthrise, Surescripts, FinThrive, athenahealth, Insight Health, and R1 are scaling rapidly to automate revenue cycle and prior authorization processes. Amperos’s agentic AI autonomously navigates payer portals and manages appeals, recovering hundreds of millions annually, while Healthrise’s Navigator AI proactively prevents claim denials by identifying upstream errors such as documentation gaps and eligibility issues that cause up to 30% of preventable revenue loss. Surescripts has expanded its Prior Authorization Automation to 68,000 prescribers, slashing prescription approval times to a median of 18 seconds by integrating directly with EHR e-prescribing workflows, a trend poised to accelerate under forthcoming CMS rules.

R1’s launch of Payer Atlas and Phare Intelligence within its Phare OS platform epitomizes the next frontier of AI-driven revenue cycle modernization by combining extensive payer API integrations with advanced natural language processing to autonomously validate claims and generate data-driven appeals. Processing over 600 million transactions annually across 1,500 payers, these tools shift healthcare billing from reactive claim management to proactive denial prevention, promising to accelerate reimbursements and transform the revenue cycle into a smartly orchestrated, efficient workflow.

By early 2026, independent practices and hospitals alike are grappling with mounting financial pressures driven by rising operating costs, revenue leakage, and increasingly complex payer behaviors. A 2026 Veradigm survey revealed that 79% of independent practice leaders see technology as essential to maintaining independence amid these challenges, with priorities focused on enhancing revenue cycle visibility and improving payer data access to reduce administrative burdens. However, many still struggle with limited real-time accounts receivable insights and delayed claim denial notifications, which exacerbate revenue loss and inefficiencies.

Hospitals face razor-thin operating margins between 1% and 3%, compounded by claim denial rates exceeding 10%, with up to 65% of denied claims never corrected and resubmitted, resulting in billions in lost revenue. Healthrise’s May 2026 launch of Navigator AI exemplifies a proactive shift, embedding AI within denial workflows to identify and correct errors early, thereby preventing denials before they occur. As Healthrise CEO David Farbman puts it, 'Denials are not the problem, they’re the symptom,' underscoring the need for real-time, actionable intelligence tailored to healthcare’s revenue cycle complexities.

The financial squeeze on specialty practices is intensifying due to an 11.1% rise in operating expenses alongside declining Medicare reimbursement rates, forcing providers to either boost revenue per patient or drastically cut labor costs. Meanwhile, payers are leveraging AI to automate claim denials and downcoding, driving a 25% increase in net revenue leakage and compelling providers to adopt AI-powered automation to appeal denials at scale. This technology shift is critical, as up to 65% of denied claims are abandoned because the cost of appeal outweighs the claim value, leaving providers to rely on AI agents that can contest every denial with zero marginal labor cost.

Fragmented revenue cycle management tools amplify financial strain by creating operational inefficiencies and revenue leakage through disconnected workflows. A 2026 industry survey found 41% of providers report claim denial rates of 10% or higher, with 54% noting increasing claim errors and 68% struggling to submit clean claims. Automation layered on these siloed systems often exacerbates errors rather than resolving them, as staff spend excessive time reconciling data instead of processing claims. Payers’ dynamic AI-driven scrutiny further pressures providers to modernize, emphasizing the critical need for integrated, interoperable solutions that prevent denials pre-submission and streamline workflows, as advocated by Availity and exemplified by R1’s Phare OS platform, which now supports over $76 billion in net patient revenue.

Hospitals are urgently pursuing operational efficiencies to counteract rising expenses—7.5% growth in 2025 outpacing price increases—and chronic underpayments, with Medicare reimbursing just 83 cents on the dollar, resulting in over $100 billion in shortfalls. Administrative costs are staggering, with $43 billion spent in 2025 on collections and denials management alone, including $18 billion dedicated to overturning claim denials. Legacy IT systems compound these pressures, prompting 71% of health IT leaders to prioritize decommissioning and archiving projects that have demonstrated multi-million-dollar annual savings and improved integration with EHRs, thereby reducing administrative burdens and compliance risks amid tightening financial constraints.

By mid-2026, AI adoption in healthcare billing paradoxically drove up costs primarily by enabling providers to capture greater billing complexity and higher-severity codes rather than increasing service volume. PwC's analysis highlighted a projected 9% rise in medical costs in the employer market for 2027, largely fueled by AI-powered documentation tools and scribes that more thoroughly record patient encounters, leading to inflated coded severity and case mix. For instance, Blue Cross Blue Shield observed a surge in the billing code for acute posthemorrhagic anemia in maternity admissions from 4% to 12.3% between 2022 and 2025, without a corresponding increase in clinical treatments, adding $22 million to maternity spending—underscoring how AI-driven coding intensity can inflate costs without improving care.

Despite these short-term cost escalations, industry experts and stakeholders maintain that AI's long-term promise lies in reducing administrative burdens and enhancing patient outcomes through proactive, precise care. Paul Markovich envisions AI ultimately eliminating much of the healthcare system's administrative overhead, while Harvard Medical School's Hossein Estiri emphasizes AI's potential to enable earlier diagnoses and fewer sick patients, potentially lowering costs substantially over time. Ric Sinclair of Cotivity echoes this optimism, describing ongoing investments in proprietary AI models designed to streamline operations across providers, payers, and pharma, aiming to transform AI from a cost driver into a cost reducer by building infrastructure that supports efficiency and near real-time payments.

However, the competitive landscape of AI adoption in healthcare reveals disparities that may entrench market advantages for large for-profit hospital operators. According to a UBS report, entities like HCA, Tenet, and UHS possess the financial and operational capacity to invest aggressively in AI technologies, outpacing nonprofit hospitals and potentially sustaining their dominance. Meanwhile, although AI-driven efficiencies in insurance administration promise industry-wide gains, UBS cautions that these financial benefits are likely to be competed away as all insurers pursue similar cost-saving measures, limiting lasting reductions in healthcare expenses.

By early 2026, Surescripts significantly accelerated prescription approvals through its expanded Prior Authorization Automation, enabling 68,000 prescribers across 42 health systems to achieve median approval times of just 18 seconds when clinical criteria were met. This automation, coupled with Real-Time Prescription Benefit tools that saved patients nearly $20 million in just four months, exemplifies how integrating AI-driven workflows and benefit transparency directly addresses affordability and access challenges. The momentum behind these innovations is poised to grow rapidly with the impending CMS Interoperability and Prior Authorization proposed rule (CMS-0062-P), which aims to further streamline prior authorization and enhance patient access at the point of care.

Bridge’s 2026 launch of its Patient Access and Revenue Suite marks a leap forward in payment modernization by unifying scheduling, billing, and payment into a seamless platform that enhances financial transparency and patient convenience. By reducing vendor fees by up to 65%, enabling loginless access via secure mobile links, embedding digital wallet payments, and automating real-time eligibility verification and text-to-pay notifications, Bridge addresses longstanding friction points in patient financial engagement and time-of-service collections.

Despite these advances, healthcare payment modernization remains hampered by entrenched legacy systems, with over 90% of insurers still relying on ACH and paper checks for core claims payouts, resulting in delays, compliance risks, and patient frustration. While real-time payment rails have gained traction for non-claims disbursements like wellness incentives, core claims lag behind due to fragmented technology, regulatory complexity, and limited insurer control over payment processors. Industry investments in system integration, fraud prevention, and automation signal a commitment to overcoming these barriers, but as Visa’s Edward Galvin observes, the ecosystem’s complexity means no single entity owns the problem, perpetuating inertia.

Visa Direct’s push to replace paper checks with card-based instant payouts addresses critical issues of speed, fraud reduction, and transparency in healthcare disbursements, where three-quarters of payments still rely on slow, risky paper methods. As Karen Webster emphasizes, patients now expect real-time payments, with delays directly impacting their financial wellbeing and ability to cover essentials like rent or out-of-pocket costs. This growing patient demand, coupled with Visa’s technological solutions, underscores a pivotal shift toward faster, more accountable payment experiences in healthcare.

By early 2026, broader AI integration in healthcare has emerged as an essential strategy to address the primary care crisis and reduce care costs, with experts like Dr. Robert Wachter emphasizing AI as an 'absolute necessity.' Companies such as Arbiter exemplify this shift by building interoperability ecosystems that create a unified, real-time source of truth across fragmented systems, streamlining prior authorizations and referrals to ensure patients receive timely care.

Despite the promise of AI, sustainable adoption faces formidable hurdles from entrenched incumbents like Epic and complex regulatory landscapes. The 'incumbency advantage' and the high-stakes nature of autonomous AI demand careful navigation of policy and market forces, while union approvals and legislative restrictions further complicate implementation, reflecting a delicate balance between innovation and workforce concerns.

The tension between acute healthcare resource shortages and fears that AI-driven efficiencies might disrupt jobs creates a paradox that will shape the pace of transformation over the next decade. This dynamic underscores the need for policies that not only accelerate AI adoption—such as Utah’s pioneering autonomous medication renewal pilot and value-based care models—but also address labor concerns to foster a sustainable and equitable modernization.

Ultimately, AI’s transformative potential lies in re-centering healthcare around patients, fostering genuine partnerships with providers that enhance quality, access, and economic outcomes. As articulated in recent analyses, there remains a hopeful vision that AI will empower patients with true agency, marking a sustainable shift in healthcare’s financial and operational models toward more patient-centric ecosystems.